{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:25:54Z","timestamp":1781018754061,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Science & Technology Development Plan of Jilin Province","award":["20140520008JH"],"award-info":[{"award-number":["20140520008JH"]}]},{"name":"Fundamental Research Funds","award":["JCKY-QKJC03"],"award-info":[{"award-number":["JCKY-QKJC03"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.pep.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T07:15:35Z","timestamp":1452150935000},"page":"73-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Establishment of a novel method without sequence modification for developing NoV P particle-based chimeric vaccines"],"prefix":"10.1016","volume":"121","author":[{"given":"Yingnan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhe","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pep.2016.01.003_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/341085","article-title":"Epidemiologic and molecular trends of \u201cNorwalk-like viruses\u201d associated with outbreaks of gastroenteritis in the United States","volume":"186","author":"Fankhauser","year":"2002","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.pep.2016.01.003_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/0470846534.ch2","article-title":"Gastroenteritis viruses: an overview","volume":"238","author":"Glass","year":"2001","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.pep.2016.01.003_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1126\/science.286.5438.287","article-title":"X-ray crystallographic structure of the Norwalk virus capsid","volume":"286","author":"Prasad","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pep.2016.01.003_bib4","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1128\/JVI.76.8.4044-4055.2002","article-title":"Structural requirements for the assembly of Norwalk virus like particles","volume":"76","author":"Bertolotti-Ciarlet","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.pep.2016.01.003_bib5","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1128\/JVI.78.12.6233-6242.2004","article-title":"The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors","volume":"78","author":"Tan","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.pep.2016.01.003_bib6","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1128\/JVI.00135-08","article-title":"Structural basis for the receptor binding specificity of Norwalk virus","volume":"82","author":"Bu","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.pep.2016.01.003_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.virol.2010.11.017","article-title":"Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles","volume":"410","author":"Tan","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.pep.2016.01.003_bib8","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1128\/JVI.00233-06","article-title":"C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein","volume":"80","author":"Tan","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.pep.2016.01.003_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jsb.2012.01.005","article-title":"Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometry","volume":"177","author":"Bereszczak","year":"2012","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.pep.2016.01.003_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2567.2011.03516.x","article-title":"A\u00a0comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles","volume":"135","author":"Tamminen","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.pep.2016.01.003_bib11","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1128\/JVI.00219-07","article-title":"Structural basis for the recognition of blood group trisaccharides by norovirus","volume":"81","author":"Cao","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.pep.2016.01.003_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virol.2008.08.047","article-title":"Noroviral P particle: structure, function and applications in virus-host interaction","volume":"382","author":"Tan","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.pep.2016.01.003_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.provac.2011.07.004","article-title":"Norovirus P particle as a platform for antigen presentation","volume":"4","author":"Tan","year":"2011","journal-title":"Procedia Vaccinol."},{"key":"10.1016\/j.pep.2016.01.003_bib14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/JVI.01835-10","article-title":"Norovirus P particle, a novel platform for vaccine development and antibody production","volume":"85","author":"Tan","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.pep.2016.01.003_bib15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/nnm.12.62","article-title":"Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus","volume":"2","author":"Tan","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.pep.2016.01.003_bib16","doi-asserted-by":"crossref","first-page":"7670","DOI":"10.1016\/j.vaccine.2011.07.139","article-title":"A\u00a0candidate dual vaccine against influenza and noroviruses","volume":"29","author":"Xia","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.pep.2016.01.003_bib17","doi-asserted-by":"crossref","first-page":"e63269","DOI":"10.1371\/journal.pone.0063269","article-title":"Norovirus P particle efficiently elicits innate, humoral and cellular immunity","volume":"8","author":"Fang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pep.2016.01.003_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.imlet.2015.09.002","article-title":"Norovirus P particle: An excellent vaccine platform for antibody production against Alzheimer's disease","volume":"168","author":"Fu","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.pep.2016.01.003_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1574888X09666131217114927","article-title":"Sphere formation assay is not an effective method for cancer stem cell derivation and characterization from the Caco-2 colorectal cell line","volume":"9","author":"Wu","year":"2014","journal-title":"Curr. Stem. Cell. Res. Ther."}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592816300031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592816300031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T09:29:12Z","timestamp":1537090152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046592816300031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":19,"alternative-id":["S1046592816300031"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2016.01.003","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of a novel method without sequence modification for developing NoV P particle-based chimeric vaccines","name":"articletitle","label":"Article Title"},{"value":"Protein Expression and Purification","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pep.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}